Blood Glucose Monitoring Devices Market - Top Companies and Manufacturers

  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Blood Glucose Monitoring Devices Landscape

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Ascensia Diabetes Care Holdings AG
    • Dexcom, Inc.
    • NIPRO CORPORATION
    • Prodigy Diabetes Care, LLC
    • ACON Laboratories, Inc.
    • Insulet Corporation
    • Ypsomed AG
    • Terumo Corporation

Browse Key Market Insights with Data Illustration:

In the News

  • Abbott Laboratories announced new data from the Real-World Evidence of FreeStyle Libre study showing the use of freestyle libre, a continuous glucose monitoring system significantly reduced the rate of hospitalizations.

  • F. Hoffmann-La Roche Ltd launched the cobas pulse system, a connected professional blood glucose management solution that builds on its inheritance with Accu-Chek Inform II. Healthcare professionals working in a variety of care settings can use this handheld blood glucose management device to monitor the blood glucose levels of patients.


Author Credits:  Radhika Pawar


  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood glucose monitoring devices is estimated at USD 20.82 billion.

The blood glucose monitoring devices market size was valued at USD 19.31 billion in 2024 and is expected to cross USD 64.98 billion by the end of 2037, expanding at more than 9.7% CAGR during the forecast period i.e., between 2025-2037. Increasing perforation of continuous blood glucose monitoring (CGM) devices, rising ubiquity of diabetes, and growing investment in diabetic research activities will boost the market growth.

North America industry is poised to dominate largest revenue share by 2037, due to rising cases of diabetes with the prevalence of obesity owing to an inactive lifestyle in the region.

The major players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample